Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biostate Extension Study in Von Willebrand Disease
NCT01224808Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Oct 2010
- Primary completion
- Mar 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 3 trial of factor viii + von Willebrand factor in von Willebrand disease (VWD), sponsored by CSL Limited. Started Oct 2010; status: completed.
02
Drugs
factor viii + von Willebrand factor
03
Conditions
von Willebrand disease (VWD)
Beyond the preview
Go deeper on NCT01224808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01224808.